GlassScriptPhysician profile
Nancy L Aiello
NPI 1821427568
$1,609.32
in general payments reported to CMS, 2019-2025
17 companies · $445 in 2025
The $445 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $261 · 2022: $151 · 2023: $347 · 2024: $406 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,099 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,099.09 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $424.79 | 2024-2025 | Keytruda, Lynparza, Welireg |
| Collegium Pharmaceutical, INC. | $319.25 | 2021-2023 | Belbuca, Xtampza |
| Nevro Corp. | $216.91 | 2022-2023 | Senza |
| Janssen Pharmaceuticals, INC | $128.85 | 2025 | Spravato |
| Pfizer INC. | $115.88 | 2024-2025 | |
| Seagen INC. | $99.00 | 2025 | |
| Myriad Women'S Health, INC. | $52.96 | 2023 | Myrisk |
| Almatica Pharma LLC | $43.90 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.32 | 2021 | |
| Beone Medicines USA, INC. | $34.16 | 2025 | Brukinsa |
| Gilead Sciences, INC. | $26.37 | 2025 | Trodelvy |
| Lilly USA, LLC | $24.02 | 2021 | |
| Recordati_rare_diseases_inc. | $21.95 | 2025 | Enjaymo |
| Biodelivery Sciences International, INC. | $19.19 | 2021 | |
| Abbvie INC. | $14.31 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $13.70 | 2023 | Tirosint, Licart |
| Uswm, LLC | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Aiello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.